Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Endothelial At-III synthesis may support local anticoagulation; hypothesis-generating for vascular biology with no clinical implications yet.
Human endothelial cells in culture is shown to synthesize antithrombin III (At-III). The endothelial cell At-III (EC-At-III) consists of a small fraction similar to plasma At-III and a larger fraction with decreased heparin-binding as tested by crossed immunoelectrophoresis. However, both the anti-Xa and thrombin-neutralizing activities of the EC-At-III were rapid and active even in the absence of added heparin. It is concluded that the major portion was probably bound to endogenous heparin-like substance, thus accounting for its decreased exogenous heparin binding. The presence of At-III and other antithrombotic factors in the vascular endothelium offer protection against thrombosis and possibly atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Chan et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: